Inspire Health Medical Group - Dermatology

CLIA Laboratory Citation Details

2
Total Citations
4
Total Deficiencyies
4
Unique D-Tags
CMS Certification Number 05D1105275
Address 2335 E Kashian Ln, Ste 410, Fresno, CA, 93701
City Fresno
State CA
Zip Code93701
Phone(559) 320-1090

Citation History (2 surveys)

Survey - June 13, 2024

Survey Type: Standard

Survey Event ID: CCLP11

Deficiency Tags: D5401 D5209 D6007

Summary:

Summary Statement of Deficiencies D5209 PERSONNEL COMPETENCY ASSESSMENT POLICIES CFR(s): 493.1235 As specified in the personnel requirements in subpart M, the laboratory must establish and follow written policies and procedures to assess employee and, if applicable, consultant competency. This STANDARD is not met as evidenced by: Based on the lack of documentation, review of testing personnel competency assessment records, and interview with the office manager (OM) and Quality Assurance Officer(QAO) on June 13, 2024, as specified in the personnel requirements in subpart M, it was determined that the laboratory failed to establish and follow written policies and procedures to assess the testing personnel competency for the years 2021, 2022, and 2023. Findings include: 1. Based on the lack of the laboratory's policies and procedures and competency evaluations' records the laboratory failed to have and follow written policies and procedures for competency assessment of the testing personnel (TP) for mycology and parasitology. 2. The laboratory fail to provide documentation of training and competency assessment for the TP performing tests of moderate complexity sample processing, testing, and reporting at the laboratory for the year 2021, 2022 and 2023. 3. This deficient practice was affirmed by interview with the OM and QAO on June 6, 2024, at approximately 12:00 p.m. 4. The laboratory reported an estimated total volume of 350 test samples in mycology and parasitology annually. The report was signed and dated by the laboratory director on 06/13/2024 for which competencies of the testing personnel were not performed. D5401 PROCEDURE MANUAL CFR(s): 493.1251(a) A written procedures manual for all tests, assays, and examinations performed by the laboratory must be available to, and followed by, laboratory personnel. Textbooks Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- may supplement but not replace the laboratory's written procedures for testing or examining specimens. This STANDARD is not met as evidenced by: Based on the lack of laboratory written policies and procedures for potassium hydroxide (KOH) and preparations for the detection of Sarcoptes Scabiei (scabies) and interviews with the office manager (OM) and Quality Assurance Officer (QAO); it was determined that the laboratory failed to have available and follow written procedures for mycology and parasitology test performed in the laboratory. The findings included: 1. On the day of the survey on June 13, 2024, at approximately 11: 45 a.m., the laboratory failed to provide written policies and procedures for histopathology test procedures performed in the laboratory. 2. For five (3) out of five (3) random patient test results reviewed from the KOH/scabies log, all the patients had mycology or/and parasitology test ordered, analyzed, and reported for which the laboratory had no written policies and procedures available. 3. The MO and QAO confirmed on 06/13/2024 at approximately 12:00 a.m. that the laboratory did not have written policies and procedures available for mycology and parasitology tests performed in the laboratory. D6007 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(1) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (E) The laboratory director must-- (E)(1) Ensure that testing systems developed and used for each of the tests performed in the laboratory provide quality laboratory services for all aspects of test performance, which includes the preanalytic, analytic, and postanalytic phases of testing; This STANDARD is not met as evidenced by: Based on observation, review of the laboratory records, and interviews with the office manager and Quality Assurance Officer; it was determined that the laboratory director failed to be responsible for the overall operation, including, but are not limited to ensure that testing systems developed and used for each of the tests performed in the laboratory provide quality laboratory services for all aspects of test performance, which includes the preanalytic, analytic, and postanalytic phases of testing. The findings included: See D5209 and D5401. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - January 20, 2021

Survey Type: Standard

Survey Event ID: 711R11

Deficiency Tags: D5217

Summary:

Summary Statement of Deficiencies D5217 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(c)(1) At least twice annually, the laboratory must verify the accuracy of any test or procedure it performs that is not included in subpart I of this part. This STANDARD is not met as evidenced by: Based on the surveyor's review of the laboratory's records for evaluation of proficiency testing performance, ten (10) random selected patient test reports from 01 /22/2019 to 10/09/2020 and an interview with laboratory personnel (LP.), it was determined that the laboratory failed to at least twice annually, document their quality assurance/proficiency testing. The Findings include: 1. On 01/20/2021 (survey date) 11:30 a.m. the laboratory personnel was unable to retrieve any documentation for least twice annually quality assurance/proficiency (peer review) for the years 2019 and 2020 for histopathology (Mohs) slide test review. 2. The laboratory personnel confirmed on 01/20/2021 at 11:30 a.m. that the twice annually quality assurance documentation for the histopathology (Mohs) slide reviews 2019 and 2020 could not be retrieved. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access